Total Payments
$7,444
2024 Payments
$463.52
Companies
29
Transactions
188
Medicare Patients
4,495
Medicare Billing
$455,503
Payment Breakdown by Category
Food & Beverage$4,395 (59.0%)
Travel$2,948 (39.6%)
Education$101.35 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,395 | 176 | 59.0% |
| Travel and Lodging | $2,948 | 10 | 39.6% |
| Education | $101.35 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $3,867 | 26 | $0 (2019) |
| Cardiovascular Systems Inc. | $415.78 | 11 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $346.89 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $300.55 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $263.46 | 13 | $0 (2024) |
| Amgen Inc. | $224.32 | 15 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $212.21 | 10 | $0 (2024) |
| Avinger Inc. | $207.71 | 2 | $0 (2021) |
| Abbott Laboratories | $199.28 | 9 | $0 (2017) |
| Tactile Systems Technology Inc | $193.55 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $463.52 | 24 | Tactile Systems Technology Inc ($161.24) |
| 2023 | $903.22 | 35 | ABIOMED ($146.65) |
| 2022 | $328.93 | 22 | AstraZeneca Pharmaceuticals LP ($85.20) |
| 2021 | $437.22 | 23 | Avinger Inc. ($115.71) |
| 2020 | $93.42 | 5 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($51.86) |
| 2019 | $428.39 | 11 | Boston Scientific Corporation ($221.66) |
| 2018 | $2,826 | 32 | BOSTON SCIENTIFIC CORPORATION ($2,406) |
| 2017 | $1,963 | 36 | BOSTON SCIENTIFIC CORPORATION ($1,239) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/02/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 11/12/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/30/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: DIABETES | ||||||
| 07/30/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 07/09/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 06/25/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Cardiovascular | ||||||
| 06/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/13/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 05/22/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.29 | General |
| Category: Medical Device | ||||||
| 04/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Not Applicable | ||||||
| 04/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DIABETES | ||||||
| 02/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: DIABETES | ||||||
| 01/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/11/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.08 | General |
| Category: Cardiology | ||||||
| 12/15/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 915 | 1,597 | $245,595 | $98,402 |
| 2022 | 20 | 1,016 | 2,067 | $267,100 | $117,728 |
| 2021 | 19 | 1,390 | 2,324 | $332,849 | $134,858 |
| 2020 | 12 | 1,174 | 1,915 | $248,991 | $104,515 |
Total Patients
4,495
Total Services
7,903
Medicare Billing
$455,503
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 299 | $59,800 | $25,964 | 43.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 103 | 301 | $30,100 | $18,340 | 60.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 78 | 86 | $23,650 | $11,487 | 48.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 46 | 47 | $13,970 | $6,715 | 48.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 16 | 121 | $7,865 | $5,023 | 63.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 83 | 84 | $25,130 | $4,338 | 17.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 18 | 36 | $7,200 | $3,722 | 51.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 20 | $30,000 | $3,647 | 12.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $6,860 | $3,121 | 45.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 19 | $5,700 | $2,584 | 45.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 24 | $4,560 | $2,407 | 52.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 17 | 68 | $3,200 | $2,270 | 70.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 17 | 123 | $6,150 | $2,165 | 35.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 21 | $2,940 | $1,925 | 65.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 124 | 136 | $6,120 | $1,373 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $2,250 | $957.18 | 42.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 15 | 15 | $4,500 | $791.70 | 17.6% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 22 | 26 | $1,300 | $514.28 | 39.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 61 | 64 | $1,600 | $396.21 | 24.8% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 22 | 26 | $780.00 | $227.76 | 29.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 27 | $270.00 | $226.80 | 84.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 11 | 11 | $1,650 | $209.11 | 12.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 119 | 434 | $43,400 | $23,808 | 54.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 104 | 120 | $31,800 | $18,229 | 57.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 134 | $26,800 | $12,762 | 47.6% |
About Dr. Ashraf Mostafa, MD
Dr. Ashraf Mostafa, MD is a Cardiovascular Disease healthcare provider based in Lapeer, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2009. The National Provider Identifier (NPI) number assigned to this provider is 1396976080.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashraf Mostafa, MD has received a total of $7,444 in payments from pharmaceutical and medical device companies, with $463.52 received in 2024. These payments were reported across 188 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,395).
As a Medicare-enrolled provider, Mostafa has provided services to 4,495 Medicare beneficiaries, totaling 7,903 services with total Medicare billing of $455,503. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Lapeer, MI
- Active Since 07/29/2009
- Last Updated 02/09/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1396976080
Products in Payments
- STINGRAY (Device) $2,360
- GENERAL - VASCULAR ACCESS (Device) $886.71
- LifeVest (Device) $346.89
- SYNERGY (Device) $296.82
- Peripheral Orbital Atherectomy System (Device) $290.63
- ELIQUIS (Drug) $220.30
- PANTHERIS (Device) $207.71
- FARXIGA (Drug) $201.51
- ENTRESTO (Drug) $199.37
- Flexitouch Plus (Device) $193.55
- Repatha (Biological) $168.87
- KENGREAL (Drug) $152.46
- Impella (Device) $146.65
- JARDIANCE (Drug) $125.08
- Absorb (Device) $124.72
- Vascepa (Drug) $121.26
- XARELTO (Drug) $117.38
- WOLVERINE (Device) $112.48
- Coronary Orbital Atherectomy System (Device) $109.41
- GENERAL THERAPIES (Device) $107.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.